107 related articles for article (PubMed ID: 12932902)
1. Synthesis and antileishmanial activity of new imidazolidin-2-one derivatives.
Robert JM; Sabourin C; Alvarez N; Robert-Piessard S; Le Baut G; Le Pape P
Eur J Med Chem; 2003; 38(7-8):711-8. PubMed ID: 12932902
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions.
Guillon J; Forfar I; Desplat V; Fabre SB; Thiolat D; Massip S; Carrie H; Mossalayi D; Jarry C
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):541-9. PubMed ID: 18035821
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.
Wert L; Alakurtti S; Corral MJ; Sánchez-Fortún S; Yli-Kauhaluoma J; Alunda JM
J Antibiot (Tokyo); 2011 Jul; 64(7):475-81. PubMed ID: 21522160
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antileishmanial activity of new 1-(pyridin-2-yl)imidazolidin-2-ones derived from 2-amino-4,6-dimethylpyridine.
Abdala H; Robert JM; Le Pape P; Wielgosz G; Robert-Piessard S; Le Baut G
Arzneimittelforschung; 2000 May; 50(5):479-84. PubMed ID: 10858876
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of 3-(imidazol- 1-ylmethyl)indoles as antileishmanial agents. Part II.
Giraud F; Loge C; Pagniez F; Crepin D; Barres S; Picot C; Le Pape P; Le Borgne M
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1067-75. PubMed ID: 19555181
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary evaluation of new ursolic and oleanolic acids derivatives as antileishmanial agents.
Gnoatto SC; Dalla Vechia L; Lencina CL; Dassonville-Klimpt A; Da Nascimento S; Mossalayi D; Guillon J; Gosmann G; Sonnet P
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):604-10. PubMed ID: 18608757
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; Fuertes M; González M; Rubiales G; Palacios F
Eur J Med Chem; 2016 Nov; 124():740-749. PubMed ID: 27639365
[TBL] [Abstract][Full Text] [Related]
11. Original antileishmanial hits: Variations around amidoximes.
Tabélé C; Faiões VDS; Grimaud F; Torres-Santos EC; Khoumeri O; Curti C; Vanelle P
Eur J Med Chem; 2018 Mar; 148():154-164. PubMed ID: 29459275
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
13. 5'-Trityl-substituted thymidine derivatives as a novel class of antileishmanial agents: Leishmania infantum EndoG as a potential target.
Casanova E; Moreno D; Gigante A; Rico E; Genes CM; Oliva C; Camarasa MJ; Gago F; Jiménez-Ruiz A; Pérez-Pérez MJ
ChemMedChem; 2013 Jul; 8(7):1161-74. PubMed ID: 23625887
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
16. 4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected disease.
Marra RK; Bernardino AM; Proux TA; Charret KS; Lira ML; Castro HC; Souza AM; Oliveira CD; Borges JC; Rodrigues CR; Canto-Cavalheiro MM; Leon LL; Amaral VF
Molecules; 2012 Nov; 17(11):12961-73. PubMed ID: 23117435
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of benzocycloalkyl azole oximino ethers: the conformationally constraint analogues of oxiconazole.
Verma A; Srivastava S; Sane SA; Marrapu VK; Srinivas N; Yadav M; Bhandari K; Gupta S
Acta Trop; 2011 Feb; 117(2):157-60. PubMed ID: 21078278
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of Tridax procumbens against promastigotes of Leishmania mexicana.
Martín-Quintal Z; Moo-Puc R; González-Salazar F; Chan-Bacab MJ; Torres-Tapia LW; Peraza-Sánchez SR
J Ethnopharmacol; 2009 Apr; 122(3):463-7. PubMed ID: 19429313
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis.
Ramírez-Macías I; Marín C; Chahboun R; Olmo F; Messouri I; Huertas O; Rosales MJ; Gutierrez-Sánchez R; Alvarez-Manzaneda E; Sánchez-Moreno M
Mem Inst Oswaldo Cruz; 2012 May; 107(3):370-6. PubMed ID: 22510833
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
